The European Medicines Agency (EMA) has begun a consultation into the use of Bayesian methods in the analysis of clinical trial data. Bayesian methods are one of the main approaches to statistical ...
As clinical drug development becomes more complex and resource-intensive, the FDA’s recent draft guidance on the use of Bayesian statistical methods in clinical trials signals a move toward more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results